Cardinal Health (CAH) announced a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 2032, reaffirming FY2027 EPS guidance of $12.40-$12.60 and long-term growth of 12%-14%.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
